Hikma Pharmaceuticals Plc Holding(s) in Company (9675V)
09 November 2017 - 3:45AM
UK Regulatory
TIDMHIK TIDM0H7D
RNS Number : 9675V
Hikma Pharmaceuticals Plc
08 November 2017
TR-1: Standard form for notification of major holdings
LONDON, 8 November 2017 - Hikma Pharmaceuticals PLC ("Hikma")
(LSE: HIK) (DIFX: HIK)
(LEI: 549300BNS685UXH4JI75), the fast-growing multinational
pharmaceuticals group, announces as
follows:
NOTIFICATION OF MAJOR HOLDINGS
----------------------------------------------------------------------------------------------------
1a. Identity of the issuer Hikma Pharmaceuticals Plc
or the underlying issuer
of existing shares to which
voting rights are attached(ii)
:
------------------------------------------------- -------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
----------------------------------------------------------------------------------------------------
Non-UK issuer
------------------------------------------------------------------------------------- -------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights x
------------------------------------------------------------------------------------- -------------
An acquisition or disposal of financial instruments
------------------------------------------------------------------------------------- -------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------- -------------
Other (please specify)(iii) :
------------------------------------------------------------------------------------- -------------
3. Details of person subject to the notification obligation(iv)
Name Deutsche Bank AG
City and country of registered Frankfurt, Germany
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
----------------------------------------------------------------------------------------------------
Name
------------------------------------------------- -------------------------------------------------
City and country of registered
office (if applicable)
------------------------------------------------- -------------------------------------------------
5. Date on which the threshold 06.11.2017
was crossed or reached(vi)
:
------------------------------------------------- -------------------------------------------------
6. Date on which issuer notified 08.11.2017
(DD/MM/YYYY):
------------------------------------------------- -------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
----------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
---------------------- ------------------------- ---------------- ---------------- -------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 3.63% 3.56% 7.19% 240,655,680
---------------------- ------------------------- ---------------- ---------------- -------------
Position
of previous
notification
(if
applicable) 3.23% 3.25% 6.48%
---------------------- ------------------------- ---------------- ---------------- -------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Class/type Number of voting rights(ix) % of voting rights
of
shares
ISIN code
(if possible)
----------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
--------------------- --------------------- -------------- ------------------------------ ---------------
GB00B0LCW083 8,705,270 33,428 3.62% 0.01%
---------------------- --------------------- -------------- ------------------------------ ---------------
SUBTOTAL
8. A 8,738,698 3.63%
---------------------- ------------------------------------- -----------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
---------------------- --------------------- -------------- ------------------------------ ---------------
Right To
Recall 310,326 0.13%
---------------------- --------------------- -------------- ------------------------------ ---------------
SUBTOTAL 8.
B 1 310,326 0.13%
-------------- ------------------------------ ---------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
--------------------- ---------------------- -------------- ----------------- ----------- ---------------
Swaps 20-Aug-24 Cash 8,264,526 3.43%
--------------------- ---------------------- -------------- ----------------- ----------- ---------------
SUBTOTAL
8.B.2 8,264,526 3.43%
----------------- ----------- ---------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which x
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
----------------------------------------------------------------- ---------------------
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
-------------------- ---------------- ----------------------- -----------------------
Deutsche Bank
Aktiengesellschaft
-------------------- ---------------- ----------------------- -----------------------
DB U.S. Financial
Markets Holding
Corporation
-------------------- ---------------- ----------------------- -----------------------
DB U.S. Financial
Markets Holding
Corporation
-------------------- ---------------- ----------------------- -----------------------
Deutsche Bank
Securities Inc
-------------------- ---------------- ----------------------- -----------------------
10. In case of proxy voting, please identify:
----------------------------------------------------------------------------------------
Name of the proxy holder
-------------------------------------- ------------------------------------------------
The number and % of voting
rights held
-------------------------------------- ------------------------------------------------
The date until which the
voting rights will be held
-------------------------------------- ------------------------------------------------
11. Additional information(xvi)
----------------------------------------------------------------------------------------
Place of completion Birmingham
-------------------- -----------
Date of completion 08.11.2017
-------------------- -----------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWSNRBAAARAA
(END) Dow Jones Newswires
November 08, 2017 11:45 ET (16:45 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024